AG
VTVT icon

Advisor Group’s vTv Therapeutics VTVT Stock Holding History

Advisor Group’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6K Hold
100
– – ﹤0.01% 4606
2019
Q3 		$6K Hold
100
– – ﹤0.01% 4598
2019
Q2 		$6K Hold
100
– – ﹤0.01% 4620
2019
Q1 		$6K Buy
100
+50
+100% +$4.85K ﹤0.01% 4611
2018
Q4 		$5K Buy
50
+20
+67% +$1.85K ﹤0.01% 4539
2018
Q3 		$1K Hold
30
– – ﹤0.01% 5016
2018
Q2 		$2K Hold
30
– – ﹤0.01% 4707
2018
Q1 		$5K Buy
30
+10
+50% +$2.45K ﹤0.01% 4435
2017
Q4 		$5K Hold
20
– – ﹤0.01% 4420
2017
Q3 		$5K Hold
20
– – ﹤0.01% 4290
2017
Q2 		$4K Buy
20
+10
+100% +$2.08K ﹤0.01% 4345
2017
Q1 		$3K Buy
+10
New +$2.28K ﹤0.01% 4311

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Group's VTVT Position: Q4 2019 in Review

Advisor Group held its vTv Therapeutics (VTVT) position steady in Q4 2019 at 100 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4606.

Advisor Group first reported a position in VTVT in Q1 2017 and has held it in 12 quarters since. 18 funds tracked by Wall St. Rank hold VTVT as of Q4 2019.

  • Advisor Group held 100 shares of vTv Therapeutics worth $6K as of Q4 2019.
  • Advisor Group left its vTv Therapeutics share count unchanged in Q4 2019.
  • vTv Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4606 holding.
  • Advisor Group first reported a position in vTv Therapeutics in Q1 2017 and has held it in 12 quarters since.
  • 18 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.